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ABSTRACT 19 
Background 20 
Self-care support refers to activities aimed at educating, training and empowering patients with skills 21 
and ability to manage [and monitor] their long-term conditions (LTCs).  While self-care support by 22 
healthcare professionals has emerged as a distinct concept in the management of LTCs, evidence of 23 
community pharmacy’s contribution is sparse. 24 
Objective 25 
The aim was to explore community pharmacy’s contribution to self-care support of LTCs.  The 26 
objectives were to explore how community pharmacists conceptualise self-care support of LTCs and 27 
how they operationalise the core elements of this in their practice. 28 
Methods 29 
Semi-structured interviews were conducted with community pharmacists in England (n=12) and 30 
Scotland (n=12).  A framework consisting of the core elements of self-care support (information and 31 
advice; skills training and support; technology; support networks; and collaborative care planning) was 32 
developed from the literature and was used to structure the interviews and analysis.  Analysis was 33 
done thematically using the interpretative phenomenological analysis technique. 34 
Results 35 
The three main themes that emerged were conceptualisation; operationalisation of the core 36 
elements; and barriers to providing self-care support.  Participants conceptualised self-care of LTCs as 37 
patients taking responsibility for their own health, performing activities that improved their LTCs and 38 
that enabled them to become more independent in managing their LTCs.  Their views on self-care 39 
support did not reflect this conceptual understanding but was described primarily as providing 40 
patients with information and advice rather than actively supporting them. Participants’ views of 41 
operationalising the core elements of self-care support was found to be medicines focussed, 42 
opportunistic and dependent on the services they provided, rather than being patient-centred and 43 
proactive.  The barriers to providing self-care support of LTCs in community pharmacy were described 44 
as priority accorded to dispensing activities, the structure of the community pharmacy contract, lack 45 
of incentives to provide self-care support and patients’ expectations and lack of awareness of 46 
community pharmacy’s role in LTCs management.  47 
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Conclusion 48 
Community pharmacists’ theoretical understanding of self-care was not reflected in the ways that 49 
they portrayed their contributions to self-care support.  The current ways in which community 50 
pharmacy delivers its services for patient care may need to be re-configured in order to fit into the 51 
holistic self-care support paradigm. 52 
 53 
KEY WORDS 54 
Self-care; self-care support; community pharmacy; long-term condition; healthcare professional; 55 
collaborative care planning 56 
 57 
ARTICLE SYNOPSIS 58 
This article presents the findings of a qualitative study that used semi-structured interviews to explore 59 
how community pharmacists conceptualised and operationalised the concept of self-care support of 60 
long-term conditions (LTCs).  The findings suggest that participants’ conceptualised self-care from a 61 
holistic perspective, but did not reflect this in how they described their support roles.  Instead, their 62 
self-care support roles were described as being primarily about providing patients with information 63 
and advice, and not actively supporting them.  Participants’ views on the core elements of self-care 64 
support indicated that their roles were medicines-focussed and opportunistic, rather than patient-65 
centred and proactive. 66 
 67 
INTRODUCTION 68 
Self-care support: A paradigm shift in the management of LTCs 69 
The term ‘self-care’, i.e. the care of oneself, refers to the everyday activities of individuals that affect 70 
their health, for example, adopting healthy lifestyles like exercising to maintain health, ensuring 71 
proper living hygiene to protect health and self-medicating to restore health.1  For people with long-72 
term conditions (LTCs), a number of these tasks can be complex and challenging, including managing 73 
the appropriate use of their own medicines, and it sometimes requires a drastic change in ways of 74 
living.2  Consequently, many people with LTCs require support, which enables them to take 75 
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responsibility for improving their health outcomes through the actions and decisions they make in 76 
their daily living.3,4  This is referred to as ‘self-care support’ (also self-management support), and is 77 
now a central component of many models of LTCs management.  Self-care support is not a new 78 
concept,5 but it has evolved with increasing acknowledgment that the current model of care, which 79 
focuses on acute, episodic care, will not meet the future demands of LTCs.6  According to the 80 
Department of Health in the United Kingdom (UK), about 70 - 80 % of the population of people living 81 
with LTCs require self-care support.7   82 
There is ample evidence to indicate that self-care support works,8 although there are divided opinions 83 
on how best to engage in it; whether through lay-led interventions9 vs. healthcare professional-led 84 
interventions;10 disease-specific vs. generic interventions;11,12 or individual vs group programmes.13  85 
One of the underlying principles of most successful self-care interventions is that they are 86 
underpinned by theories of behaviour change,14 such as the self-regulation or common sense model,15 87 
the social cognitive theory,16 the theory of planned behaviour17 and the transtheoretical (‘stages of 88 
change’) model.18   89 
In the UK, health policy has been evolving radically with a key priority on inculcating patient-centred 90 
self-care support into the culture and practice of health-care professionals (HCPs).19  Successive UK 91 
governments have attempted to restructure and reform how the National Health Service (NHS), the 92 
main, publicly funded healthcare provider in the UK, organises and delivers care to people with LTCs.  93 
Self-care support is a key component of the NHS model for the management of LTCs outlined in 2006.20  94 
This model, adapted from the widely accepted chronic care model,21 emphasises the key roles that 95 
patients play in the success or failure of their own treatment and care.22  It also advocates for a change 96 
in the current HCP-patient relationship and interaction, from the traditional paternalistic approach, to 97 
one that puts patients at the centre of their own care and one that supports them to undertake self-98 
care.23  Self-care support involves all activities aimed at educating, training and empowering patients 99 
with skills and ability to monitor their conditions in order to maintain a satisfactory quality of life.24 100 
Managing LTCs in community pharmacy; is there a place for self-101 
care support? 102 
The role of community pharmacists worldwide is evolving from a traditional ‘backroom’ dispensing 103 
role to one where pharmacists are now front-facing and getting actively involved in patient care, 104 
particularly for people with LTCs.25  In the UK, community pharmacy supply patients with their 105 
prescribed medicines through dispensing and repeat/serial dispensing services, in addition to playing 106 
expanded roles of supporting patients to get the best out of their medicines and improve their health 107 
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outcomes.  The role expansion of community pharmacists has seen an increase in the range of services 108 
targeted at people with LTCs being developed, commissioned and delivered in community 109 
pharmacies.  However, due to the devolution of some legislative powers to the individual countries of 110 
the UK (England, Scotland, Wales and Northern Ireland), there are some differences in the way that 111 
services targeted at LTCs are organised in the community pharmacy contractual framework in the 4 112 
countries.  The Medicines Use Reviews (MURs) and the New Medicine Service (NMS) are the foremost 113 
LTC services in community pharmacy in England while it is the Chronic Medication Service (CMS) in 114 
the Scotland.26,27  In addition to providing these LTC services, community pharmacists are also required 115 
to provide patients with advice when dispensing their prescribed medicines28 116 
Although the ways that the MUR, NMS and CMS are structured and operationalised are different, they 117 
all essentially aim to extend the roles of pharmacists in patients’ medication and disease management 118 
with the objectives of improving patients’ knowledge, understanding and adherence to medications 119 
therapy to improve health outcomes.26,29  The MUR introduced in 2005 and the NMS introduced in 120 
2011, are advanced services in the community pharmacy contract in England, meaning that 121 
community pharmacists can choose whether or not to provide them. The MUR service targets LTC 122 
patients on certain types of medicines or those recently discharged from hospital while the NMS 123 
targets particular groups of patients on newly prescribed medicines.  Community pharmacists need to 124 
be trained and accredited to provide both the MUR and NMS and remuneration for these services is 125 
based on a ‘fee-per-service’ model, where payment is based on meeting a set target on the number 126 
of MUR/NMS undertaken.30  On the other hand, the Scottish CMS, introduced in 2010, is offered at all 127 
pharmacies across Scotland and requires patients with LTCs to voluntarily register with a community 128 
pharmacy of their choice to receive pharmaceutical care as part of a shared agreement between the 129 
patient, the pharmacists and the doctor.29  Community pharmacists are trained and supported to 130 
provide the CMS by their local health boards and by the NHS Education for Scotland Pharmacy.31  The 131 
CMS relies on electronic systems in place in Scotland and remuneration is based on a ‘capitation 132 
model’ of payment.31 133 
In other parts of the world, there are comparable, albeit differently organised and delivered services.  134 
For example, in the United States (US), there is the Medications Therapy Management (MTM);32 while 135 
in Australia, there is a similar MUR service (MedsCheck) in addition to different disease state 136 
management interventions such as Diabetes Medication Assistance Service (DMAS)33 and the 137 
Pharmacy Asthma Care Program (PACP).34 138 
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The evidence base for these medicines management services, and their impacts and benefits on 139 
improving clinical, economic and humanistic outcomes are inconclusive.  For example, while some 140 
evidence from the UK suggest that services such as the NMS improves outcomes like patients 141 
adherence to medicines,35 some other studies have suggested that community pharmacists’ 142 
contributions to the care of LTCs is growing but have yet to be fully realised.36,37  Whereas, evidence 143 
emanating from evaluation of interventions such as the MTM, DMAS and PACP indicate that 144 
community pharmacy’s contributions are significant and valuable in improving a whole range of 145 
outcomes.38-41  A recent systematic review and meta-analysis of pharmacist-led medication review 146 
however found some benefits of pharmacists‘ interventions on outcomes such as improved clinical 147 
outcomes, reduced hospitalization and reduced mortality.42  148 
Self-care support as a concept in the management of LTCs is not a language that is commonly used in 149 
community pharmacy.43  The roles of HCPs and primary care teams in self-care support of LTCs have 150 
been explored extensively in the field of medicine and nursing, and evidence indicates that this has 151 
significant benefits.8    However, there is very little published evidence in pharmacy practice.43  The 152 
majority of the published work in pharmacy has focused on very specific aspects such as medication 153 
reviews,36 medication management,44 adherence to medications,45 and disease-specific 154 
interventions.46  Self-care of LTCs by HCPs is however described as a much more multidimensional 155 
holistic concept that looks at how care is provided to the patient as a whole not as separate, single, 156 
disease-specific interventions.47 157 
 158 
Study aim and objectives 159 
The overall aim of this study was to explore the contribution of community pharmacy to providing 160 
self-care support to patients with long-term conditions (LTCs).  The objectives were to explore how 161 
community pharmacists conceptualise self-care support of LTCs and how they operationalise the core 162 
elements of this in their practice. 163 
 164 
METHODS 165 
Identifying the core elements of self-care support of LTCs 166 
Early on in this research study, a narrative review of the literature was undertaken to identify the 167 
different aspects of self-care support of LTCs that have been published.  This review highlighted the 168 
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paucity of published evidence on self-care support of LTCs in the pharmacy literature.   Most of the 169 
key self-care evidence were published in the medical, nursing and psychology literature, as well as in 170 
Government policy papers.  A scoping and synthesis of the key literature and government policy 171 
papers3,8,13,19,20,48-60 45,61-68identified from this narrative review process led to the development a single 172 
framework that brought together the core elements of self-care support of LTCs (Figure 1).  This 173 
framework emerged after the literature was examined to identify and summarise the overarching 174 
themes in the self-care support interventions. The elements of self-care support in this framework 175 
also reflect the broad research interest areas and interventions around self-care support.   A brief 176 
description of each of the core elements in this framework is provided below. 177 
Figure 1 – Core elements of self-care support of long-term conditions (LTCs) 178 
 179 
Collaborative care planning 180 
Collaborative care planning refers to the collaborative interaction between patients and HCPs, where 181 
the perspectives and expertise of both are shared and used to provide personalised care and 182 
support.50  Collaborative care planning is the central element of the framework and reflects its central 183 
role in enhancing the effectiveness of the other elements of self-care support.  Self-care support 184 
interventions that embed collaborative care planning utilise behaviour change techniques such as 185 
motivational interviewing and health coaching51-53 to target specific patient outcomes such as self-186 
efficacy.  Collaborative care planning is aligned with the principles of other concepts such as shared 187 
Collaborative 
care planning
Information 
and advice
Skills 
training and 
support
Technology
Support 
networks
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decision-making,54,55 patient engagement, involvement and partnership with HCPs,56 patient-centred 188 
care57 and patient empowerment. 189 
Information and advice 190 
Almost all self-care support interventions involve provision of information and advice through patient 191 
education to help to improve patients’ knowledge and understanding of living with LTCs, and to enable 192 
them to engage in self-care.8  While the nature and structure of information and advice provided to 193 
patients vary according to the type of LTC and the individual patient circumstances, the self-care 194 
education approach differs from the traditional patient education approach.  The main distinction is 195 
that in self-care education, patients are provided with personalised and tailored information and 196 
advice based on individual needs (e.g. health literacy, health beliefs, etc.), while in the traditional 197 
approach, patients are provided with standardised, generic and sometimes unsolicited information 198 
and advice.13 199 
Skills training and support 200 
In addition to information and advice, some self-care support interventions aim to train and support 201 
patients to develop certain skills required managing and living with their LTCs.  Some of these skills 202 
include self-monitoring skills,8 coping skills to deal with, and respond to changes in LTC signs and 203 
symptoms,58 self-administration of certain medicines such as inhalers,59 and adherence and ability to 204 
effectively use prescribed medicines.45  205 
Support networks 206 
Many self-care support interventions involve patients coming together in groups and networks, where 207 
practical support and help about caring for LTCs are offered to patients with limited involvement of 208 
their HCPs.60  Self-care support networks can be grouped into 361; personal communities such as 209 
family/carers, friends, peers; non-HCP support such as social workers, health trainers; and voluntary 210 
and community groups that includes self-help support groups such as the Chronic Disease Self-211 
Management Programme (CDSMP)62 and the Expert Patient Programme.63 212 
Technology 213 
A wide range of technologies to improve self-care of LTCs is emerging and HCPs play a key role in 214 
supporting and encouraging patients to engage in these technologies.  These technologies include 215 
information technologies,64 mobile applications (‘apps’),65 web-based tools,66 and assistive, ‘smart’ 216 
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home technologies.67,68  These self-care support technologies are now being incorporated into many 217 
self-care support interventions that support people with LTCs at home.67 218 
 219 
Study design 220 
A qualitative approach was taken with the aim of uncovering how community pharmacists 221 
conceptualised self-care support and how they viewed and operationalise its core elements (Figure 1) 222 
in their practices.  The use of semi-structured interviews allowed in-depth exploration of the ideas and 223 
views with individual pharmacists.  This method was underpinned by the philosophical stance of 224 
phenomenology which proposes that the ‘lived experience’ of an individual can only be understood 225 
by obtaining a detailed account of the individual’s reality.69  The study adopted interpretative 226 
phenomenological analysis (IPA) approach (hermeneutics) to draw out the meaning of the accounts 227 
provided by community pharmacists, while also acknowledging and “bracketing” the preconceptions 228 
and role of the researchers.70 229 
Study Setting 230 
The study was set in the North West of England (Greater Manchester) and in 4 of the 32 council areas 231 
of Scotland (Glasgow, Dundee, Perth and Angus).  Both England and Scotland were included in this 232 
study because of the differences in the ways that community pharmacy in both countries delivers their 233 
foremost LTC services. 234 
Recruitment 235 
Recruitment of participants into this study took place between January and July 2013.  Recruitment 236 
and sampling was undertaken purposively allowing for maximal variation71 in pharmacy types; 237 
multiples and independents, location; urban, rural, supermarket, geographical area; deprived, 238 
affluent, mixed and pharmacist demographics; ethnicity, age, gender.  While there is no conventional 239 
guidance in determining the appropriate sample size for interviews in qualitative research, there is 240 
general agreement that the sample size should be determined when theoretical data saturation has 241 
been reached.72  However, this study predetermined the sample size of participants (twelve 242 
participants each in England and Scotland) according to the recommendation of Guest et al to allow 243 
for the above mentioned maximal variation.73  Data saturation was reached after the 10th interview in 244 
England and after the 8th interview in Scotland.  All interviews were however included for analysis. 245 
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In England, community pharmacists were recruited by approaching them through Local 246 
Pharmaceutical Committees (LPCs), representing all community pharmacists within each of the 10 247 
primary care trusts (PCTs) (now clinical commissioning groups) in Greater Manchester.  An 248 
introductory email attached with the study’s recruitment pack (containing a letter of invitation and 249 
participant information sheet) was sent to the coordinator/secretary of each LPC to forward to its 250 
members.  Four LPCs responded to indicate that they had forwarded the study’s recruitment pack to 251 
its members.  Further participant recruitment was undertaken by randomly searching the NHS direct 252 
website for the contact details of community pharmacies located within each of the four LPCs that 253 
responded.  Community pharmacists were then contacted and invited to take part in the study by 254 
email, telephone and/or post.  Snowballing, which involved one participating pharmacist referring 255 
another pharmacist friend or colleague to participate was also employed in some cases to identify 256 
other potential participants.74  A total of 55 community pharmacists were identified and approached 257 
with 12 successfully recruited and interviewed. 258 
In Scotland, community pharmacists were recruited through contacts in the pharmacy departments 259 
at the Health Boards of NHS Tayside, NHS Greater Glasgow and Clyde, and NHS Lothian.  The contacts 260 
were provided, via email, with the study’s recruitment pack, which was then used to invite potential 261 
participants into the study.  The names and contact details of 18 community pharmacists that were 262 
interested in taking part in the study were forwarded directly to the research team by the contacts 263 
that helped in identifying and recruiting them.  Of the 18 potential participants, 12 successfully 264 
recruited and interviewed.  The higher rate of success of recruitment in Scotland compared to England 265 
was due to the fact that potential participants in Scotland had already indicated interest in taking part 266 
in the study before being contacted by the researcher.  This was not so in England. 267 
Data collection 268 
Semi-structured interviews were conducted by the lead researcher face-to-face at either the 269 
participants’ place of work or other agreed location (e.g. coffee shops).  Interviews with participants 270 
in England were conducted between January and July 2013 while interviews with participants in 271 
Scotland were conducted in April 2013.  Interviews lasted between 40 and 70 minutes and were audio-272 
recorded following written and signed consent.  Handwritten notes were also taken during and after 273 
the interviews.   274 
The interview topic guide 275 
The interview topic guide (Box 1) was developed from existing literature on self-care support of LTCs 276 
with a key focus on the core elements of self-care support described above (figure 1).  The guide 277 
P a g e  | 11 
 
evolved iteratively as interviews progressed and made use of open-ended questions.  Prompts and 278 
cues were used extensively during the interviews, particularly during discussions around the core 279 
elements of self-care support.  This is described further under the relevant subsections of the results 280 
section. 281 
Box 1:  The topic guide 282 
Broad topic area Primary questions/topic area 
Background in community 
pharmacy 
Can you provide me with an overview of education and career in 
community pharmacy? 
- Years of experience; postgraduate education; CPD and trainings 
undertaken, type(s) of practice and services offered? 
Managing/supporting 
people with LTCs 
Can you describe the nature and types of LTCs encountered in 
your practice?  Most common ones? Single vs multiple morbidity? 
 Can you describe your general approach to manage/support 
people with LTCs?  Please use examples to illustrate this. 
- Interacting with LTC patients; roles of team members LTC 
services (MURs, NMS, CMS), lifestyle management, others 
Knowledge and 
understanding of SC and 
SCS 
Can you describe your understanding of the term ‘self-care’ in 
relation to LTCs? 
- What comes to mind?  How do you think LTC patients undertake 
self-care?  What does this entail? 
 How do you support LTC patients to undertake self-care based on 
the way you have described it? 
- Can you use and example to illustrate this? When do you 
provide SCS? Opportunities for SCS?  Who else is involved? 
Operationalizing the 5 
Elements of self-care 
support of LTCs 
Information and advice 
- Nature of the pharmacist-patient interaction? Types of 
information and advice provided?; Assessing patients knowledge 
and understanding? 
 Skills training and support  
- Supporting self-monitoring of LTCs signs and symptoms and 
supporting patients on coping?; Supporting self-monitoring with 
tools and devices?; Supporting self-administration of medicines 
(e.g. inhalers); supporting adherence to medicines? 
 Support networks  
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- Involving patients’ family/carers?; Signposting/referring to 
support networks (online or in the community)?  Other support 
groups? 
 Self-care technology  
- Awareness and use of self-care technologies to support 
patients?; Internet resources and mobile/smart phone 
applications (‘apps’); other technologies 
 Collaborative care planning 
- Getting involved in care planning with patients and other HCPs?; 
Developing partnerships with patients; shared decision making; 
goals-setting and follow up; problem-solving; motivating patients; 
Use of behaviour change counselling approaches motivational 
interviewing and CBT? 
Barriers to providing self-
care support 
What are the main barriers that hinder you from providing self-care 
support [for each of the core elements] for people with LTCs? 
Data analysis 283 
All audio files were stored digitally on a secure computer network drive.  Interviews were transcribed 284 
verbatim and anonymised, and textual data were managed and retrieved using the QSR NVIVO 285 
software (version 10).  Data analysis was done thematically75 combined with the IPA technique.76  IPA 286 
is not simply about categorisation of data, but it requires a close interaction between the 287 
researcher/analyst and the data.77  The IPA approach was a cyclical and iterative process, and it 288 
involved familiarisation with the data by initially reading through the interviews, which led to a 289 
preliminary coding structure (broad categories with many themes and sub-themes). The framework 290 
for the elements of self-care support (figure 1) was used in the preliminary coding structure for 291 
relevant sections of the data to capture themes and subthemes that related to it. Connection of sub-292 
themes and themes were then made, which involved shifting back and forth from themes and sub-293 
themes in the data through close reading and re-reading of the text.  The coding and interpretation 294 
process was a continuous and extensive review and modification of the current and emergent sub-295 
themes, themes and categories, until a final summary structure was decided.  The coding of the 296 
interview data was undertaken by the first author (OO) and the coding structure and interpretation 297 
was regularly reviewed and agreed by the co-authors.   298 
Ethical consideration 299 
The study received the NHS Research Ethics Committee (REC) approval and Research and 300 
Development (R&D) approvals/permission from NHS SalfoR+D in Greater Manchester in England and 301 
the relevant Health Boards in Scotland. 302 
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 303 
RESULTS 304 
Presentation 305 
Twelve interviews were conducted with community pharmacists in England, and another 12 in 306 
Scotland.  Following a summary of participants’ demography, findings are presented under 3 broad 307 
themes; conceptualization of self-care support; operationalization of the core elements of self-care 308 
support; and barriers to providing self-care support.  Quotations are used to illustrate the findings 309 
from each emergent theme or subtheme.  Early analysis in the study indicated that the views of both 310 
English and Scottish participants were very similar and so the findings are presented together.  Each 311 
interview participants was given a unique identification number, with English community pharmacists 312 
coded as ‘ECP’ and Scottish as ‘SCP’.   313 
Participants 314 
The demographic characteristics of the study participants are summarised in table 2.  Participants 315 
worked in a wide range of locations; in rural to urban areas, in deprived and affluent areas, as well as 316 
on high streets and supermarkets.  All participants in England provided both the MUR and NMS and 317 
all but one participant in Scotland provided the CMS.  The one participant in Scotland who did not 318 
provide the CMS stated that her community pharmacy was in the process of commencing the service 319 
and was in the process of undertaking the required training.  320 
Table 2:  Demographic characteristics of study participants by Country (England and Scotland) 321 
Variable England (n = 12) Scotland (n = 12) 
Age Mean age = 34.4 years, SD = 7.7 Mean age = 41.6 years, SD = 8.1 
Gender Male = 58% 
Female = 42% 
Male = 58% 
Female = 42% 
Ethnicity White = 33% 
Asian = 25% 
Black = 42% 
White = 83% 
Asian = 17% 
Black = 0% 
Pharmacy Type Multiple = 67% 
Independent = 33% 
Multiple = 58% 
Independent = 42% 
Pharmacist Role Pharmacy Owner = 8% 
Pharmacy Manager = 75% 
Locum Pharmacist = 17% 
Pharmacy Owner = 17% 
Pharmacy Manager = 75% 
Locum Pharmacist = 8% 
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 322 
Conceptualising self-care support of LTCs  323 
In order to unpack how community pharmacists’ conceptualized self-care support of LTCs, participants 324 
were asked to describe their understanding of the  term ‘self-care’ before going on to describe if and 325 
how they supported patients to engage in self-care and the opportunities that they took to provide 326 
support.  This allowed for insights to be gained into their conceptual understanding of self-care 327 
support and provided the baseline for further exploration of how self-care support was 328 
operationalised in practice using the core elements as a structure. 329 
Understanding of self-care 330 
All participants provided a description of their understanding of the term ‘self-care’ in relation to LTCs.  331 
The views of most participants on the meaning of self-care suggested that they understood its core 332 
principles which is about patients taking responsibility for their own health and care, and getting more 333 
involved in managing their LTCs.  Many participants described self-care as activities that patients got 334 
involved in, to improve their knowledge, understanding and confidence of living with and managing 335 
their LTCs themselves, rather than being reliant on healthcare professionals and healthcare resources.  336 
There was a general consensus that patients undertaking proper self-care are required to take the 337 
lead in taking the necessary positive actions, making informed decisions and getting actively involved 338 
with their healthcare professional in how their health is managed to the extent that they became 339 
independent. 340 
“um, self-care would be to the point where the patient obviously get enough knowledge about 341 
their condition, and about medications, that they are on to the point that they are quite 342 
confident and be able to effectively manage the condition through lifestyle, through taking 343 
their medicines…” SCP014 344 
While discussing their understanding of self-care, almost all participants indicated that the use of 345 
medicines was the key self-care activity for patients, where the patients become knowledgeable on 346 
the importance of safely and appropriately taking their medicines.  The majority of participants 347 
suggested this by using medicines-related examples to illustrate and describe what they understood 348 
as patients undertaking self-care.   For example, some participants described self-care activities as 349 
patients knowing how to properly and safely administer and manage their medicines while at home, 350 
while some others suggested that self-care was when patients were able to adhere to their medicine 351 
regimen and deal with any problems they encountered with them in order to achieve the desired 352 
therapeutic outcomes.  Some participants however also noted that, in addition to this medicines-353 
related component of self-care, it also involved patients taking other actions such as undertaking self-354 
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monitoring and symptom management or making lifestyle changes in order to effectively manage 355 
their LTCs.  On the whole, what was overwhelming from the views of majority of the participants was 356 
that self-care was predominantly medicines-focussed as the use of medicines was viewed as being the 357 
top priority for patients in relation to other activities. 358 
“Self-care, um, is that sort of just you know patients managing their own medicines and you 359 
know, sort of, you know, things like just measuring their own pressure, and having like a blood 360 
pressure machine to do that.  And um, I suppose diabetics doing their own tests and things 361 
would be part of self-care.”…SCP019 362 
Engaging in self-care support 363 
Participants allowed further insights into how they conceptualised self-care support by discussing if 364 
and how they supported their patients with LTCs to engage in self-care based on the description of 365 
self-care that they had provided.  Almost all participants indicated that they were, in some ways, 366 
already engaged in providing self-care support.  They suggested that they did this by providing patients 367 
with the necessary information and advice to enable them to undertake self-care.  Self-care support 368 
of LTCs, according to most participants was about making patients more knowledgeable.  369 
“um, I suppose it’s just making them more knowledgeable isn’t it, just kinda giving patients 370 
the information to be able to self-care I think, um, yea”….SCP020 371 
Similarly to their description of self-care, most participants indicated that the primary focus of self-372 
care support was to educate patients to make the best use of their medicines, although some 373 
participants also added that they also took the opportunity to address non-medications-related issues 374 
and/or offered other relevant information and advice to patients.  A few participants however 375 
recognised that self-care support went beyond promoting the appropriate use of medicines.  In 376 
particular, the participants talked about moving towards a more patient-focussed approach 377 
(inadvertently suggesting that their current approaches were not sufficiently patient-focussed), where 378 
they addressed patients’ overall health needs rather than just concentrating on the use of their 379 
medicines.   380 
“Ok.  What also, um, having mentioned that, it’s not just medications that we deal with, we 381 
also deal with lifestyle advice.  So if you got a patient sort of, seem to be like diabetic patients, 382 
you sort of conducting the test, blood glucose, quite high, oh you need to recommend, oh you 383 
know, cut your blood sugar down, you know, and have more vegetables and all that, lose 384 
your weight.  You know, doing that test and also um, you know advising the patient, they 385 
change their lifestyles quite dramatically.  So I think you know, [we] moving towards self-care 386 
and also um, patient focussed approach. Yea, so, you know those patients needs to be 387 
addressed”  ECP006 388 
There was a general belief by many participants that self-care support was already being provided to 389 
patients by other HCPs (particularly primary care nurses) hence, their own self-care support roles were 390 
to reinforce what patients should already know.  In particular, many participants shared this view 391 
when discussing their roles in providing patients with self-care information and advice. 392 
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“um if it’s a LTC, you would have thought that all the other professionals would have provided 393 
relevant information at every stage, so when you come to speak to them, you are just 394 
reinforcing what knowledge they already have…ECP004 395 
On the whole, most participants readily recognised the importance of self-care in helping people with 396 
LTCs to better manage their health.  Some participants went further to discuss the benefits of self-397 
care support to both patients and to them as HCPs.  The participants indicated that supporting self-398 
care support was important in; improving patients’ health outcomes; reducing waste in the NHS; and 399 
relieving pressure on community pharmacists and other health professionals. 400 
 “I think that self-care is probably the most important thing in managing LTCs, I mean, the 401 
healthcare workers can only try to help the patient.  But the patient is the one that has the 402 
major role, you know.  I mean, things ranging from making sure you use your medications 403 
and you know, and I mean it think it’s extremely important and it makes every other persons 404 
jobs easier” ECP012 405 
Opportunities to provide self-care support 406 
After providing insights into their conceptual understanding of self-care support of LTCs, participants 407 
went on to discuss the opportunities they took to provide self-care support in their community 408 
pharmacies.  Unsurprisingly, almost all participants indicated that the core LTC services within their 409 
contractual frameworks – the MUR and NMS in England and the CMS in Scotland – provided the main 410 
opportunities for them to support self-care of LTCs.  Most participants indicated that the majority of 411 
their LTC patients were on regular medicines and they simply dispensed these to them, unless they 412 
were due for their scheduled review or consultation (usually yearly), or if there was a change in 413 
medication, where they would fulfil their contractual obligations by providing the appropriate 414 
consultation service. 415 
“in practice, there’s a lot of repeat dispensing.  So, obviously, we have the same patients that 416 
come in every month for their medication, medication that is stable, um, and it’s just a case 417 
of dispensing them.  So if there’s anything new, then I’ll just counsel them accordingly, but, a 418 
lot of times, you are over here sitting down with them to do an MUR, possibly once a year.  419 
Um, unless it’s a new medication, do the new medicines service (NMS)”. ECP003 420 
While some participants indicated that they occasionally had interactions with patients over the 421 
counter when handing out prescription medicines, most participants admitted that the LTC services 422 
that they provided were sometimes the only contact that they had with patients with LTCs. Many 423 
participants suggested that when these services were introduced, they formalised and provided a 424 
contractual structure to the things that they were already doing in practice.  They suggested that the 425 
LTC services provided them with a checklist of the things they had to cover with patients when 426 
providing the services. 427 
 “But I do find the CMS, I think, what it’s done is it’s given us a structure to kinda work through, 428 
because you walk through one part and you go and you kinda go through those questions. 429 
So it is good to kinda make sure that you’ve done all, I think it’s questions that we’ve always 430 
asked…” SCP024 431 
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 432 
Operationalising the core elements of self-care 433 
support of LTCs 434 
Information and advice 435 
Having indicated that their self-care support roles were primarily about providing patients with 436 
information and advice through patient education, participants were then probed further about how 437 
they provided and delivered these information and advice.  Most participants recognised that they 438 
were an important source of information to patients with LTCs although a few participants suggested 439 
that this was still a potential that had not yet been fully harnessed.  It appeared that self-care 440 
information and advice was delivered to patients via the traditional patient education approach where 441 
they provided generic, structured information and advice, rather than by the self-care education 442 
approach which takes a tailored, personalised approach to identifying the barriers that may exist for 443 
patients to put the information into practice13.  Participants suggested this by indicating that they 444 
provided patients with as much information and advice as they deemed necessary since they were 445 
usually very busy to spend the time to identify and assess the information needs of patients. 446 
 “So, yea, you can have a little chitchat, but in general if you want to get to the nitty-gritty, 447 
then, you have to be very direct and give as much information as possible, explain to them 448 
as much as possible.  But like I said in pharmacy practice, if you are working in a busy store, 449 
you are never really going to get the chance to fully go through the ins and outs of patients’ 450 
medicines.”  ECP010 451 
After discussing a predominantly service-driven and medicines-focussed approach to providing 452 
information and advice, some participants had to be prompted to discuss if, and what other types of 453 
information and advice that they provided, particularly with supporting lifestyle change.  Some 454 
participants went on to indicate that they provided lifestyle support services such as stop smoking 455 
schemes, weight management programmes, NHS health checks, screening services such as blood 456 
pressure and cholesterol testing, and health lifestyle promotion through the display of leaflets. 457 
I advise them on what it should be, um, but, you know it’s the follow up, that’s it, that’s the 458 
hardest thing, following up…. We do, like free blood pressure monitoring, we do um, we check 459 
their weights, check their BMI, things like that….um, we do blood glucose monitoring for free.  460 
So, if anything is highlighted from there, then obviously, you advise them accordingly, so um, 461 
if your blood pressure if high, you say ok, moderate exercise, diet. Maybe advise them on 462 
what proportion of, you know, um, meat they should have in their diet, and what proportion of 463 
you know, carbs and etcetera.  If they are really overweight, then, we do like a lipotrim diet.  I 464 
might recommend them to go on that.  ECP003 465 
However, it appeared that lifestyle support was mostly undertaken opportunistically during 466 
interactions with patients with LTCs as many participants indicated that they would only normally 467 
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offer lifestyle information and advice when the opportunity came up during their conversation, or 468 
when a patient requested a related service or product (e.g. smoking products).   469 
The only time though you may have to do lifestyle counselling or intervention is when um, a 470 
patient requests for a product for example like quit smoking.  So, at that point, that’s an 471 
opportunity for you to um, chip-in some lifestyle advice or counselling really at that point.  Um, 472 
but other than that, you don’t, if you are handing out scripts, as long as you know you have 473 
established that the patient knows what he/she is doing with the medication, you don’t offer 474 
any lifestyle advice. ECP007 475 
Some participants also indicated that most patients had already been provided with the relevant self-476 
care information by other healthcare professionals (mainly doctors and nurses), and that their roles 477 
were essentially to reinforce this information.  In addition, some participants also suggested that they 478 
sometimes avoided providing patients with too much information in order to avoid overloading them.  479 
They indicated that they would rather provide the basic information and encourage the patient to 480 
contact them if there was anything that was unclear to them. 481 
“um, usually, one of the things that I would do in fact, I do it with every prescription is to say 482 
if you get home, and you have any other questions, my name is [named pharmacist] and I 483 
write it on the bag label, and the telephone number is at the bottom….And they have just 484 
been in the consultation with the GP, they are just coming to you.  So, leaving that door wide 485 
open and saying you can phone us anytime, it’s not a problem, even if it is simple things, 486 
don’t worry about it, just phone and ask.”….SCP013 487 
Participants had different views on how they thought patients used the self-care information they 488 
provided to them.  While some participants indicated that they had a duty to ensure that the 489 
information they provided made patients more knowledgeable to make informed decisions, some 490 
other participants suggested that their responsibilities ended with providing the information and 491 
patients would ultimately decide on what they did with the information.  The latter participants went 492 
on to indicate that most patients, especially those that had been taking the same medications for 493 
some time were quite knowledgeable already and that there was no point in repeating the same 494 
information to them.  495 
“You are giving out the medication which patients have been taking for years, there is no point 496 
though, referring such patients.  You don’t even bother to ask whether the patient is um, if 497 
they’ve had their medications before, so you assume that they know what they are doing with 498 
the medication” ECP008 499 
 500 
Skills training and support 501 
Participants were asked to discuss self-care skills in relation to patients’ needs, and if and how they 502 
provided support in helping patients to acquire these skills.  Many participants initially struggled to 503 
identify any self-care skills that they supported and had to prompted with examples in some cases.  504 
The skills discussed with participants include coping skills to deal with the impact of LTCs, self-505 
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monitoring of LTC signs and symptoms, use of self-monitoring tools and devices and support with self-506 
administration of certain medicines (e.g. inhalers and insulin injections).  Most of the discussions with 507 
participants however were centred on skills training and support with the use of self-monitoring tools 508 
and devices and with self-administration of certain medicines. 509 
Use of self-monitoring tools and devices 510 
The majority of participants indicated that their involvement in skills support was limited to supplying 511 
patients with self-monitoring tools and devices.  Most participants mentioned blood pressure 512 
monitors (digital sphygmomanometers), blood glucose monitors (kits and strips) and cholesterol test 513 
kits that they had for sale in their pharmacy stores.  They however suggested that they would not 514 
proactively offer patients these devices unless patients made specific requests for them.  Participants 515 
also pointed out that once they had sold the device to patients they rarely got involved in how patients 516 
used the tools and devices, or in interpreting the results and clinical signs, unless there was a request 517 
for help by a patient.  Many participants however further stated that they would prefer to refer 518 
patients back to their GPs if there were any concerns about the test results.   519 
“The best time is when somebody gets the first treatment for blood pressure, and then I would 520 
be, um, encourage them to purchase and have it in place, that they could check it, not 521 
necessarily every 15 minutes, but just regularly and not worry unduly about it, but to keep an 522 
eye on the situation and if there are any changes they can then speak to the GP…. that’s an 523 
area where I probably would be even, I’ll say if it…speak to your GP, but again that could be 524 
um, a CPD point I could develop.” SCP018 525 
In addition to supplying self-monitoring tools to patients, some participants indicated that they had 526 
free health check services like blood pressure service and body mass index (BMI) checks which they 527 
offered to patients with LTCs as well as to the general public that visited the pharmacy.  When probed 528 
further about supporting patients with self-monitoring at home, some participants said that they did 529 
not proactively encourage patients to engage in this because they were cautious that some could get 530 
unnecessarily worried about fluctuating readings.  Participants indicated that while they sometimes 531 
provided advice to patients about the general use of self-monitoring devices, they would mainly refer 532 
them back to their specialist nurses if the patient had any concerns. 533 
“A lot of patients now have their own [BP] machines… sometimes, I worry that they get too 534 
overly involved.  So, cholesterol checking and like glucose measurements frighten me 535 
because of the training I’ve had... Just saying you know, that’s just such a snapshot, if they 536 
are really worried you know, come and see the nurses or whatever.  So when they come in 537 
and ask for that, we explain obviously what it may be and then refer them to the Surgery.  And 538 
the nurses there, they’ve got lead nurses in each practices,” SCP024 539 
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Support with self-administration of medicines 540 
For LTCs like asthma and Chronic Obstructive Pulmonary Disease (COPD) that require patients to self-541 
administer medicines with different types of inhalers and volumatic spacer devices, participants 542 
indicated that they provided support to patients with using these devices correctly during medicines 543 
consultations, e.g. MUR or CMS.  There were however indications from a number of participants that 544 
they only got involved with this opportunistically.  They indicated that they assumed that patients 545 
already knew how to use these devices because they were already being seen by their specialist 546 
(asthma) nurses or GPs and would have been shown how to use these devices.  They suggested that, 547 
while they would offer support to patients that made requests for help, they would usually refer most 548 
of them back to their GPs and nurses. 549 
“Many of them have been shown how to use, because a lot of them you’ll say, but do you 550 
know how to use the inhaler, they say, yes, the doctor showed me but I didn’t quite understand 551 
it. So, most of them have been shown how to use it, wherever, either by the GP or the nurse.” 552 
ECP001 553 
Support networks   554 
Participants were asked about their knowledge and use of support networks or groups when 555 
interacting with patients with LTCs.  Many participants initially appeared unsure about this and had to 556 
be prompted with illustrations and examples that support networks included individuals, 557 
organisations or resources, within or outside the healthcare sector, where patients could get more 558 
information and/or support with living with their LTCs. There was a consistent theme among most 559 
participants that the patient’s GP or nurse was the first point of call if they perceived that there was 560 
an issue that they could not handle.  When probed further about patient self-help/support groups, 561 
most participants indicated that they were aware of national support groups that focused on different 562 
types LTCs (e.g. British Heart Foundation), or local lifestyle support groups.   563 
 “um, in terms of local groups, there is, we can refer them into the kind of smoking cessation 564 
um, groups as well.  There is some referral pathways within [named support group], which is 565 
the alcohol pathways, I think it’s called [another named support group], is one of the ones you 566 
can refer them into, um, to get people help with their alcohol consumption. ”SCP022 567 
While signposting to these types of support groups is an essential component of the English 568 
community pharmacy contract, it appeared that most participants did not actively get involved in this.   569 
“Um, there are support networks, however, I personally have not recommended that, oh, go 570 
to, other than going to see their, say diabetic nurse or asthma nurse, or, um, I’ve not 571 
recommended any support group personally.” ECP005 572 
The reason for this is not very clear, but a few participants reflected that although they knew of these 573 
groups, the reason for not using them maximally to support patients was attributed to the fact that 574 
they were not too confident about providing appropriate information about the groups to patients. 575 
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“Um, but generally, no, I wouldn’t say I do that particularly regularly.…well, yea maybe it’s 576 
just that we feel unconfident, I don’t really know myself, exactly, where that could go for help.  577 
Um, we kinda you know, I’ve heard of these things, but you know, I don’t know that patients 578 
would sign up to get emails or whatever. So it’s probably just the fact that I don’t know myself.” 579 
SCP019 580 
On the whole, it emerged that participants had limited awareness of patient self-help/support groups.  581 
Some participants indicated that they had a list and contact details of patient self-help groups, but it 582 
appeared that they were not proactively signposting patients to these groups.  Some participants 583 
indicated that they predominantly referred patients to these groups during dedicated periods of 584 
health promotion campaigns, or when the groups approach them to display their leaflets and posters.  585 
“Um, unless, you know, as part of the public health campaign, the PCTs might ask us to carry 586 
out some self-care campaigns for them, get involved with like, displaying posters, establishing 587 
you know, what services are available, um, when and how to see the doctor, how to refer 588 
themselves and things like that.” ECP007 589 
Technology   590 
Participants were asked about their knowledge, awareness and use and any forms of self-care 591 
technologies in supporting patients with LTCs.  There was a general consensus among almost all 592 
participants that the use of self-care technologies to support patients with LTCs in community 593 
pharmacy was very limited.  Most participants referred to the use of telephone (to follow up or make 594 
enquiries) and internet technologies (mainly via signposting patients to relevant websites) as the main 595 
way of using technology to support their patients.  A few participants however described one-off, 596 
innovative approaches in supporting self-care with technology where they helped to meet particular 597 
patients’ needs, for example, in using a patient’s smartphone to set alerts/reminders about medicines 598 
use and appointments to improve adherence.   599 
“We have tried um to help a patient in the past with regards to timings of medication, with 600 
Parkinson’s disease.  Um, and the women were saying I just cant get to grasps if I don’t know 601 
what am going to do.  Um, and the girls programmed her mobile phone with the times, so that 602 
that would go as an alarm.  So simple things like that make a lot of difference to patients you 603 
know.  Um, coz she’s like I don’t even know how you work the phone, and one of the girls 604 
said let me show you how to do it coz I would be rubbish [laughs].  The girl said no no, its 605 
really, like you know and it would off at those times every single day.  So compliance was 606 
much better, yea, that makes a difference.”  SCP018 607 
On the whole however, participants indicated that although they were aware of emerging 608 
technologies such as tele-health and mobile application technology (‘apps’) available to patients with 609 
LTCs, they were not currently using these to support patients.  Most participants however recognised 610 
that there was a potential place for such technologies in community pharmacy, in particular with 611 
mobile technology to support patients with taking their medications, since almost all their patients 612 
now had smart phones. 613 
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“No, but it’s certainly something I think we should be getting involved in because it’s the way 614 
forward and other industries are certainly doing it.  And I guess I’m also conscious of the fact 615 
that if we don’t do it, someone else will” SCP013 616 
 617 
Collaborative care planning 618 
Collaborative care planning, which is at the centre of the implementation strategy for self-care support 619 
of LTCs, is a process where both the healthcare professional and patient bring together their expertise 620 
to offer personalised support to the patient.50  While almost all participants recognised the importance 621 
of collaborative care planning in helping patients to change behaviours to manage their LTCs, it 622 
appeared that they were not engaged in using this strategy in their interactions with patients.  There 623 
was a general agreement among most English participants that care planning was beyond the remit 624 
of their responsibilities as community pharmacists.   They indicated that it was more of the 625 
responsibility of the patient’s direct care teams in GP surgeries (doctors and/or nurses), especially 626 
since they had access to individual patient’s information and records.  Some participants however 627 
indicated they had previously been informally involved in aspects of care planning, particularly around 628 
a patient’s medicines and inferred that their contributions were of value. 629 
“Well, my opinions of things like care-planning, I think it’s the nurses, the doctors and all that 630 
that draw the care-plans.  Not us in the community, yea... Yea, it would be nice for the 631 
pharmacist to input in the care-plan and to see how we can work it.  Sometimes, we do get 632 
involved, um, especially, between carers, coz we’ve had some patients where they’ve had 633 
difficulties with medication, say, um, they can only get carers in the morning and teatime, and 634 
we’ve put tablets at night time.  So they ring us, so what do we do, should we combine it with 635 
morning, should we give it at teatime, is it safe. We do get involved in things like that.  So, it 636 
would be nice, say, if a pharmacist was there when all the decisions were being made.  And 637 
the pharmacists can say, oh, this, this and that can work.  So yea, rather than when the whole 638 
decisions have been finalised…” ECP005 639 
Even among Scottish participants who are contracted to provide pharmaceutical care planning as part 640 
of the Chronic Medication Service (CMS), their views suggested that they did not engage 641 
collaboratively in care planning with their patients and/or other healthcare professionals.  From the 642 
ways that participants described the involvement of patients in the pharmaceutical care planning 643 
process, it appeared that they basically got patients to consent to taking part in the service, rather 644 
than getting them to be actively involved in the process.  Care planning as described by participants 645 
involved the pharmacist identifying and reviewing any pharmaceutical related issues that the patient 646 
might be experiencing and informing and educating patients about it, and then recording it in the  647 
appropriate paper work. 648 
…it’s agreed with the patient, well the patient, from it yea, you would conduct the care plans, 649 
the patient knows what you are doing, and then that gets all recorded. You review anything 650 
that is necessary to review...” SCP014 651 
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A prerequisite to undertaking effective collaborative care planning is that healthcare professionals see 652 
patients as active partners and involve them in making decisions about the care of their LTCs.  While 653 
most participants indicated that they had good relationships with the majority of their regular patients 654 
with LTCs, it appeared that their interactions with them were more paternalistic rather than active 655 
partnerships.  While some participants indicated they had 2-way discussions with their patients and 656 
asked open questions in order to elicit discussions, most suggested that they mostly provided the 657 
information and advice that they deemed were necessary.  However, most participants having 658 
acknowledged the difficulty of getting patients to come forward with information during their 659 
conversations with them, stated that having an open kind of conversation would gradually put 660 
patients at ease with them and more willing to open up and work in partnership.  A few participants 661 
also suggested that might sometimes use their own personal experience to help patients in making 662 
decisions. 663 
“yea, well, you provide them with information anyway.  You can advise them that you think 664 
this is the best, but it’s still up to them really….If you have had experience with some of these 665 
medications, I’ll say oh yea, I know this treatment, I’ve tried it and I’ve had.  So yea, personal 666 
preference might be giving them more information about it so that they can make their 667 
informed choice.” ECP011 668 
An essential component of collaborative care planning in self-care support is goal-setting (or 669 
implementation intentions) and active follow-up which aims to help effect and sustain behaviour 670 
change.  Analysis of participants’ views suggested that active goal-setting and follow-up were not 671 
implementation strategies that were routinely used in community pharmacy practices unless they 672 
were delivering contracted services that had goal-setting and follow-up built into them.  For instance, 673 
when talking about goal-setting and follow-up, almost all participants described the smoking cessation 674 
service, weight management service and the New Medicine Service (NMS) in England as situations 675 
where they helped patients to set goals and follow-up. 676 
“yea we do… you might do that [set goals and follow-up] when you sell them some products 677 
or when you offer the stop smoking service, or like patients on medication for obesity like 678 
Orlistat.  Um, part of the things you do is to agree with patient um, their goal really.  Because 679 
over certain period, you expect them to have lost certain weights.  So you can agree with 680 
them that well, over certain period, other things being equal, we expect you to have lost this 681 
weight, or you have achieved this state really…. Um, smoking cessation as well, you can do 682 
that with them when you say, when do you want to quit smoking?  You agree with them, when 683 
do you want to quit smoking, you know, by so, so week, you should have quit…yea, so you 684 
that.” ECP007 685 
On the whole, many participants acknowledged that they were currently not implementing many 686 
aspects of collaborative care planning and identified this as a weakness of community pharmacy 687 
practice.  Many participants however indicated that they encouraged patients to check back with them 688 
if they had any concerns about their LTCs.  689 
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“again that’s probably one of the weaknesses where in pharmacy we don’t really support the 690 
change of somebody who comes down.  Um, what I can do sometimes is to say, look if you 691 
are struggling, come back and see me.” …SCP023 692 
 693 
Barriers to providing self-care support 694 
While almost all participants recognised community pharmacy’s potential to contribute more in 695 
managing LTCs and supporting self-care of LTCs, they also identified and discussed barriers that 696 
hindered them.  Some participants identified and discussed specific barriers to operationalising 697 
aspects of the core elements of self-care support while some others discussed the broader barriers to 698 
providing general support and patient-centred care to people with LTCs.  One of the main barriers that 699 
was shared by almost all participants however, was the current nature of their professional roles, 700 
which still required them to spend the bulk of their time in the dispensaries to prepare and check 701 
prescriptions, with little time to spare to interact with, and support patients.   702 
Um, I think there’s um, I think we haven’t got there yet, as a profession, um in community.  703 
We are not there yet.  We are restricted in the roles that we are in because we are busy in 704 
the dispensaries, so, especially, a lot of the independents, um, so, it is difficult to be able to 705 
get the time to play more of a role in terms of long-term conditions.  …ECP008 706 
In particular, many participants suggested that increasing volume of prescriptions and inadequate 707 
support staffing levels were increasing their workload, making it more difficult for them to find the 708 
time to speak with patients.  Some participants however believed that these barriers were not 709 
insurmountable and went on to share their experience of some of the ways that they were tackling 710 
some of these challenges. One participant believed that the right support team could be developed 711 
over time to free up the pharmacists’ time to speak with patients. 712 
And I think we are doing some work on that because if you are sole pharmacist in a really 713 
busy pharmacy, and you maybe don’t have the support team in place, that can be tricky.  We 714 
are lucky, we’ve worked hard over the last 5 years to get the support team there, and often I 715 
think we need 2 checking technicians and not just one, to let the pharmacists to go and speak 716 
to the patients.  But um, well baby steps, we are getting there. …SCP018 717 
However, not many participants were optimistic about how the underlying factors that hindered them 718 
from creating the time to speak to patients could be addressed. Many participants stated that with 719 
the current structure of community pharmacy, they did not think that they would be able to free up 720 
their time away from the dispensary because of growing patient population with increasing 721 
prescription workloads  722 
well, the truth is I don’t see us spending more time with our patients, if anything we are going 723 
to spend less time because the patient population is growing and the demand for 724 
pharmaceutical care [prescriptions] is growing.  So, pharmacy profession is getting under 725 
more pressure really to deliver those services within less time, so, I don’t see it 726 
happening….ECP007 727 
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Many participants also identified the funding structure of the contractual services and activities that 728 
they currently provided to patients with LTCs as being another important barrier to providing self-care 729 
support.  This view was particularly shared particularly strongly by participants in England, where they 730 
indicated that there were currently no incentives within their contracts for them to provide self-care 731 
support since their main source of revenue was based on the number of prescription items, as well as 732 
on a target number of services (MURs and NMS).  Many of these participants also stated that, in order 733 
to remain in business, their employers were more interested in community pharmacy services and 734 
activities that generated revenue rather than on activities such as self-care support, that put demand 735 
on the scarce resource of the pharmacists’ time.  736 
So the only real time we will sit down with the patient is during the MUR.  Yea…the barriers 737 
are that we are restricted to, we have at to be at the pharmacy [dispensary].  The pharmacy 738 
[dispensary] can’t function without us.  Um you know, that’s probably the biggest barrier.  And 739 
employers, um, will look at um, what’s in it for them, its money.  Um, you know, because they 740 
are out to make money, the patient care um, isn’t really given the priority, unless, there is a 741 
monetary value attached to it. ...ECP012 742 
Participants also discussed patients’ awareness and expectations of the role of community pharmacy 743 
in the care of their LTCs as a barrier to providing self-care support.  While participants generally agreed 744 
that some patients valued the interventions and support activities that community pharmacy 745 
provided, most participants believed that many patients are yet to fully understand the support roles 746 
that community pharmacy could play, aside supplying them with their medicines. For example, in the 747 
quote below, the participant talked about her reluctance to provide inhaler technique support to 748 
patients because patients perceived that the pharmacy setting was not the right place for that, hence, 749 
her support roles were limited to ‘friendly advice’.    750 
And maybe we can give advice on inhaler techniques as well, but um, patients can be quite 751 
strange, they could be quite rare, not too bothered to talk about it, they can be quite rare to 752 
come and have consultation with me and sort of be seen that way, you know, they’ve got their 753 
asthma nurse, you know, and they would see those along in the surgeries.  So, they are 754 
happier to see, you know, maybe people like that in the GP setting.  But in the pharmacy 755 
setting, there is very much this tendency towards, you know, your customer would rush in, 756 
get their medications and thank you, run out again.  That’s kind of all they want from you.  757 
Some patients are different but certainly, so we tend to limit our interaction in terms of long 758 
term care, to sort of friendly advice….SCP017 759 
Most participants went on to identify and discuss other barriers that hindered their individual 760 
contributions to self-care support, such as communication and working relationship with other HCPs 761 
and the need to improve their knowledge, understanding and confidence in specific areas of self-care 762 
support.  On the whole, many participants expressed the belief and willingness that they could 763 
contribute more to self-care support of LTCs. 764 
we would love to do that (collaborative care planning), but unfortunately, the way pharmacy 765 
is setup at the moment, we are not able to access that and we seem to be pushed. And to 766 
think we are cheaper than the specialist nurses, we’ll love to.  The fact that we have these 767 
rooms, so, with some extra training, we would want the extra training, we want to do it well.  768 
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As a pharmacist, speaking for myself, we would love to take on some of these roles. 769 
…ECP002 770 
Despite the barriers discussed, most participants appeared to be cautiously optimistic of community 771 
pharmacy playing a key role in future, in self-care support of LTCs.  Some participants believed that 772 
the key challenge for community pharmacists lies in how to combine new roles and make the 773 
transition from their traditional dispensing roles and responsibilities to a patient-centred, self-care 774 
support role. The quote below sums up the views of most participants on whether self-care support 775 
of LTCs in community pharmacy could be operationalised in practice. 776 
/yea, I don’t see why that shouldn’t be the case, you know, I think pharmacists are definitely 777 
capable of doing it [taking a lead in self-care support], we’ve got enough knowledge….I can’t 778 
comment on England, but I think in Scotland, there is a transition from working from basically, 779 
dispensing prescriptions, from counting beans, putting tablets out, you know, looking at the 780 
interactions and basically deal with that, to a more patient-centred approach.  I think it’s quite 781 
a difficult shift.  Maybe it isn’t, maybe that’s my perception….But um, I think that marrying up, 782 
doing prescriptions and actually speaking with patients the whole time which is what seems 783 
to be the way that pharmacy is going, is um, is quite difficult.  I don’t see, I just can’t see in 784 
my head how the 2 marry up, and how you can maybe effectively run both things, um, 785 
presumably there is a way of doing it [laughs], but um, I’ve not heard of it yet….SCP017 786 
 787 
DISCUSSION 788 
There were no notable differences in the views of participants in England and Scotland despite the 789 
differences in the ways that community pharmacy LTC services are organised and delivered in both 790 
countries.  This study showed that while community pharmacists had some general understanding of 791 
the theoretical principles of self-care of LTCs, they did not translate this to the systematic practice of 792 
self-care support.  Participants suggested that self-care support in community pharmacy was primarily 793 
about providing patients with the information and advice to enable them to undertake self-care. While 794 
information and advice helps to improve patients’ knowledge and understanding on how to care for 795 
their LTCs, there is clear evidence that providing information and advice alone is insufficient in 796 
effecting  and sustaining behaviour change.8  Many successful self-care support interventions are 797 
grounded and underpinned by theories of human behaviour4 and incorporate active behaviour change 798 
techniques such as cognitive behavioural therapy, behaviour change counselling and motivational 799 
interviewing in helping to change patient behaviour.78  Self-care support interventions utilise these 800 
targeted behaviour change techniques to ensure that information and advice provided to patients 801 
results in improved self-efficacy,79 which in turn results in behaviour change.  Some participants in this 802 
study discussed certain instances where they used behaviour change techniques to provide 803 
information and advice to patients, for example in the use of goal-setting and proactive follow-up 804 
when providing lifestyle services like stop smoking interventions.  While they provided anecdotal 805 
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evidence of the success of these interventions, it appeared that they did not apply these techniques 806 
in their routine practice and only used it because it was part of a service. 807 
This study explored how the core elements of self-care support were described and operationalised 808 
by participants.  In general, participants appeared to freely discuss the core elements of information 809 
and advice and collaborative care planning, while probes and cues were used extensively to encourage 810 
them to discuss skills training, support networks and technology to support self-care.  On the whole, 811 
it was found that operationalisation of self-care support of LTCs in community pharmacy was more 812 
opportunistic and reactive, rather than systematic and proactive.  Information and advice provided to 813 
patients with LTCs focuses predominantly on the use of medicines while other information and advice, 814 
for example to improve lifestyle, is provided opportunistically.  Furthermore, it also appeared that the 815 
approach taken by community pharmacists to provide information and advice to patients during a 816 
consultation followed the didactic, traditional patient education approach, rather than the patient-817 
centred, self-care education approach.13  This approach has been conceptualised by some authors as 818 
being a transmission model, rather than a transaction model.80  While the nature of the community 819 
pharmacist-patient consultation was not within the scope of this study, this finding was consistent 820 
with those of other studies that examined the pharmacist-patient interaction, which found that 821 
interactions were characterised by very brief, one-way communication, with the use of closed 822 
questions and a focus on information about medications.80-82 823 
Skills training and support is an aspect of self-care education where patients are actively supported to 824 
learn and acquire specific skills that empowers them to live and care for their LTCs.83  While the self-825 
care skills training and support required by patients vary according to their individual needs, this study 826 
found community pharmacists do not currently provide active skills training and support in their 827 
routine interactions with patients. There may however be opportunities that community pharmacists 828 
can take to support patients, for example, when they supply patients with self-monitoring devices, 829 
they could take the opportunity to support patients in the correct use of the device as well as in 830 
ongoing monitoring and interpretation of the test results.  Similarly, it was found that other types of 831 
skills training and support, such as in helping patients with their inhaler techniques are mostly 832 
undertaken opportunistically, rather than proactively in community pharmacy.  There is evidence of 833 
incorporating skills training and support in inhaler techniques into routine community pharmacy, 834 
through the commissioning of services such as the Greater Manchester Community Pharmacy Inhaler 835 
Technique Service.59   However, in the report on the evaluation of the service59, it appears that the 836 
focus of this service is more about the inhaler itself (medicines-focussed), rather than on other 837 
important determinants of good asthma control (patient-centred care).  This further reinforces the 838 
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finding that community pharmacists’ approach to providing self-care support is focused on how the 839 
medication worked for the patients (medicines-focussed approach), rather than on how patients used 840 
their medicines (patient-centred approach).43 841 
Support networks and the use of technology are now increasingly being recognised as important 842 
elements of self-care support of LTCs, although they have not been given as much consideration in 843 
research as the other elements.   This study however found that community pharmacists do not 844 
currently routinely engage with these elements in their interaction with patients with LTCs.  For 845 
example, with support networks, community pharmacists in England are contractually required to 846 
refer and signpost patients with LTCs to support groups but this study found that participants tended 847 
to do so only opportunistically.  The study found that in community pharmacy, there was even less 848 
awareness and use of any innovative technologies such as smart phone applications and telemedicine 849 
to support self-care for patients with LTCs.  This finding, in addition to the dearth of published studies 850 
that have examined support networks and use of technologies in self-care support further 851 
demonstrates the limited service provided by community pharmacy to people with LTCs. 852 
Collaborative care planning is at the heart of the framework of the core elements of self-care support, 853 
and this reflects its central role in bringing together all the other elements at the point of interaction 854 
between the patient and the HCP.  Many other models of care of LTCs, such as the Five A’s of self-855 
management support84 and the ‘house of care’ model50 include collaborative care planning as their 856 
central component.  Collaborative care planning is an interactive, cyclical process where both the 857 
patient and the HCP are involved in the care process, and includes steps such as action planning and 858 
documentation, goal setting, proactive follow-up.50,84  The findings from this study also indicate that 859 
collaborative care planning is not yet seen as part of community pharmacy practice in the 860 
management of LTCs.  However, a recent study provided evidence that pharmacists can help patients 861 
with asthma to set and achieve their asthma management goals if collaborative goal setting is 862 
incorporated into community pharmacy’s strategy for managing asthma.85  Also, proactive follow-up 863 
is an essential part of collaborative care planning, to review and reinforce goals set with patients.  Yet, 864 
this study found that it is not undertaken routinely and systematically in community pharmacy, unless 865 
a service such as the NMS was being provided. 866 
The main barriers to providing self-care support according to participants in this study include; priority 867 
accorded to dispensing in community pharmacy; the structure of the current NHS community 868 
pharmacy contractual framework; lack of incentives for self-care support of LTCs; and patients’ 869 
expectations and lack of awareness of community pharmacy’s potential.  These barriers are similar to 870 
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those of other studies that have qualitatively examined community pharmacy’s enhanced roles in 871 
supporting LTCs.86  Community pharmacy’s professional identity has traditionally been defined by its 872 
role in dispensing medicines;87 hence it is not surprising that self-care support of LTCs is medicines-873 
focussed.  874 
However, the landscape of healthcare services for LTCs has now changed towards a more pluralistic 875 
and patient-centred one, which focuses less on medicines but more holistically on the patient.  876 
Meanwhile the nature and range of services provided by community pharmacy are shaped by the NHS 877 
pharmaceutical contractual framework which is largely based on fee-per-service/item remuneration.  878 
Moreover, some studies have found that the quality of many of these community pharmacy services 879 
is substantially influenced by pharmacy owners’ commercial interests.88,89  This context and approach 880 
is likely to curtail the motivation of community pharmacists in providing support in a more patient-881 
centred way.  In order for community pharmacy to contribute meaningfully to the self-care support 882 
paradigm, there is a need to significantly rethink and redesign how pharmacy LTC services are 883 
organised and delivered, as well as how pharmacists (and pharmacy staff) are remunerated and 884 
incentivised to provide self-care support.  Recognition of the fact that community pharmacy (and 885 
pharmacy profession as a whole) is yet to realise its potential in contributing to, and improving patient 886 
care has led to recent and ongoing consultations and debates in the UK about the future shape and 887 
scope of community pharmacy.90,91 888 
Strengths and limitations 889 
This study explored the perspectives of a small sample of community pharmacists in England and 890 
Scotland on their understanding of self-care support as a concept in the management of LTCs and how 891 
they applied this concept in their professional practice.  The maximal variation sampling strategy 892 
adopted in this study ensured that participants that were sampled reflected the variety of community 893 
pharmacists working in practice. A limitation of this study was that a single coder was used in the 894 
coding and interpretation process of the data analysis and respondent validation of the final coding 895 
framework was not undertaken.  However, validation of the data coding and interpretation was 896 
enhanced via regular review and agreement of the data analysis process by the coder’s supervisory 897 
team which consisted of 3 academic researchers with acknowledged experience and expertise in 898 
qualitative data analysis. 899 
To the best of our knowledge, this is the first time that self-care support as a distinct concept in the 900 
management of LTCs has been explored among community pharmacists in the UK.  In addition, this 901 
study examined community pharmacists’ views in relation to the wide range of LTCs that they 902 
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encountered in practice, rather than focussing on specific single diseases, which is reflective of the 903 
real world scenario, since people with LTCs often live with multiple co-morbid conditions.  The majority 904 
of other studies that have examined the potential of community pharmacy practice to undertake self-905 
care support have focused on single LTCs such as diabetes and asthma.  The process of designing and 906 
developing this study lead to the emergence of a single framework which summarised the core 907 
elements of SCS of LTCs.  To the best of our knowledge, no similar framework of this such exists in the 908 
community pharmacy literature and this framework may be used to inform and design interventions 909 
and future work in this area. 910 
 911 
CONCLUSION 912 
Healthcare services and the healthcare needs of patients with LTCs are changing significantly.  Self-913 
care support and other related concepts such as patient-centred care, shared decision-making, patient 914 
involvement, patient empowerment, now indicate the direction of travel in which healthcare services 915 
are heading.  The self-care support agenda is the future in the management of LTCs and community 916 
pharmacy needs to identify and delineate its contributions to self-care support and also engage with 917 
the wider multidisciplinary teams in primary care to implement it.  The language and structure of self-918 
care support in community pharmacy needs to be aligned with that of the wider healthcare team.  919 
Future work is currently being undertaken to establish how generalizable the findings of this study are 920 
in a much larger, statistically-representative survey of community pharmacists in England. 921 
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